Nitric Oxide (NO) Synthase Inhibitors: Potential Candidates for the Treatment of Anxiety Disorders?
Open Access
Abstract
Close to 19% of the world population suffers from anxiety. Current medications for this chronic mental disorder have improved treatment over the last half century or more, but the newer anxiolytics have proved disappointing, and enormous challenges remain. Nitric oxide (NO), an intra- and inter-cellular messenger in the brain, is involved in the pathogenesis of anxiety. In particular, excessive NO production might contribute to its pathology. This implies that it might be useful to reduce nitrergic activity; therefore, molecules aiming to downregulate NO production such as NO synthase inhibitors (NOSIs) might be candidates. Here, it was intended to critically review advances in research on these emerging molecules for the treatment of anxiety disorders. Current assessment indicates that, although NOSIs are implicated in anxiety, their potential anti-anxiety action remains to be established.Keywords
This publication has 99 references indexed in Scilit:
- The Anti-inflammatory Effect of Melatonin on Methamphetamine-Induced Proinflammatory Mediators in Human Neuroblastoma Dopamine SH-SY5Y Cell LinesNeurotoxicity Research, 2012
- Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson’s diseaseMetabolic Brain Disease, 2007
- Anxiolytic effects induced by inhibition of the nitric oxide–cGMP pathway in the rat dorsal hippocampusPsychopharmacology, 2007
- Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of ratsPsychopharmacology, 2005
- Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- Regulation of striatal dopamine neurotransmission by nitric oxide: Effector pathways and signaling mechanismsSynapse, 2002
- 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxietyPsychopharmacology, 1997
- Selective pharmacological inhibition of distinct nitric oxide synthase isoformsBiochemical Pharmacology, 1996
- Nitric oxide induces neurotransmitter release from hippocampal slicesEuropean Journal of Pharmacology, 1992